BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders
Brain-derived neurotrophic factor (BDNF) has a unique role in the neuronal development, differentiation, and survival in the developing and adult nervous system. A common single-nucleotide polymorphism in the pro-region of the human BDNF gene, resulting in a valine to methionine substitution (Val66M...
Saved in:
| Published in: | Aging and disease Vol. 9; no. 3; pp. 523 - 536 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
JKL International
01.06.2018
JKL International LLC |
| Subjects: | |
| ISSN: | 2152-5250, 2152-5250 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Brain-derived neurotrophic factor (BDNF) has a unique role in the neuronal development, differentiation, and survival in the developing and adult nervous system. A common single-nucleotide polymorphism in the pro-region of the human BDNF gene, resulting in a valine to methionine substitution (Val66Met), has been associated with the susceptibility, incidence, and clinical features of several neurodegenerative disorders. Much research has been dedicated to evaluating the effects of polymorphism in the past decade, and functional effects of this genetic variation. A better understanding of how this naturally occurring polymorphism associates with or influences physiology, anatomy, and cognition in both healthy and diseased adults in neurodegenerative conditions will help understand neurochemical mechanisms and definable clinical outcomes in humans. Here we review the role and relevance of the BDNF Val66Met polymorphism in neurodegenerative diseases, with particular emphasis on glaucoma, multiple sclerosis (MS), Alzheimer's disease (AD) and Parkinson's disease (PD). Several controversies and unresolved issues, including small effect sizes, possible ethnicity, gender, and age effects of the BDNF Val66Met are also discussed with respect to future research. |
|---|---|
| AbstractList | Brain-derived neurotrophic factor (BDNF) has a unique role in the neuronal development, differentiation, and survival in the developing and adult nervous system. A common single-nucleotide polymorphism in the pro-region of the human BDNF gene, resulting in a valine to methionine substitution (Val66Met), has been associated with the susceptibility, incidence, and clinical features of several neurodegenerative disorders. Much research has been dedicated to evaluating the effects of polymorphism in the past decade, and functional effects of this genetic variation. A better understanding of how this naturally occurring polymorphism associates with or influences physiology, anatomy, and cognition in both healthy and diseased adults in neurodegenerative conditions will help understand neurochemical mechanisms and definable clinical outcomes in humans. Here we review the role and relevance of the BDNF Val66Met polymorphism in neurodegenerative diseases, with particular emphasis on glaucoma, multiple sclerosis (MS), Alzheimer’s disease (AD) and Parkinson’s disease (PD). Several controversies and unresolved issues, including small effect sizes, possible ethnicity, gender, and age effects of the BDNF Val66Met are also discussed with respect to future research. Brain-derived neurotrophic factor (BDNF) has a unique role in the neuronal development, differentiation, and survival in the developing and adult nervous system. A common single-nucleotide polymorphism in the pro-region of the human BDNF gene, resulting in a valine to methionine substitution (Val66Met), has been associated with the susceptibility, incidence, and clinical features of several neurodegenerative disorders. Much research has been dedicated to evaluating the effects of polymorphism in the past decade, and functional effects of this genetic variation. A better understanding of how this naturally occurring polymorphism associates with or influences physiology, anatomy, and cognition in both healthy and diseased adults in neurodegenerative conditions will help understand neurochemical mechanisms and definable clinical outcomes in humans. Here we review the role and relevance of the BDNF Val66Met polymorphism in neurodegenerative diseases, with particular emphasis on glaucoma, multiple sclerosis (MS), Alzheimer's disease (AD) and Parkinson's disease (PD). Several controversies and unresolved issues, including small effect sizes, possible ethnicity, gender, and age effects of the BDNF Val66Met are also discussed with respect to future research. Key words: BDNF, polymorphism, neurodegenerative diseases, glaucoma, multiple sclerosis, Alzheimer's disease Brain-derived neurotrophic factor (BDNF) has a unique role in the neuronal development, differentiation, and survival in the developing and adult nervous system. A common single-nucleotide polymorphism in the pro-region of the human BDNF gene, resulting in a valine to methionine substitution (Val66Met), has been associated with the susceptibility, incidence, and clinical features of several neurodegenerative disorders. Much research has been dedicated to evaluating the effects of polymorphism in the past decade, and functional effects of this genetic variation. A better understanding of how this naturally occurring polymorphism associates with or influences physiology, anatomy, and cognition in both healthy and diseased adults in neurodegenerative conditions will help understand neurochemical mechanisms and definable clinical outcomes in humans. Here we review the role and relevance of the BDNF Val66Met polymorphism in neurodegenerative diseases, with particular emphasis on glaucoma, multiple sclerosis (MS), Alzheimer's disease (AD) and Parkinson's disease (PD). Several controversies and unresolved issues, including small effect sizes, possible ethnicity, gender, and age effects of the BDNF Val66Met are also discussed with respect to future research.Brain-derived neurotrophic factor (BDNF) has a unique role in the neuronal development, differentiation, and survival in the developing and adult nervous system. A common single-nucleotide polymorphism in the pro-region of the human BDNF gene, resulting in a valine to methionine substitution (Val66Met), has been associated with the susceptibility, incidence, and clinical features of several neurodegenerative disorders. Much research has been dedicated to evaluating the effects of polymorphism in the past decade, and functional effects of this genetic variation. A better understanding of how this naturally occurring polymorphism associates with or influences physiology, anatomy, and cognition in both healthy and diseased adults in neurodegenerative conditions will help understand neurochemical mechanisms and definable clinical outcomes in humans. Here we review the role and relevance of the BDNF Val66Met polymorphism in neurodegenerative diseases, with particular emphasis on glaucoma, multiple sclerosis (MS), Alzheimer's disease (AD) and Parkinson's disease (PD). Several controversies and unresolved issues, including small effect sizes, possible ethnicity, gender, and age effects of the BDNF Val66Met are also discussed with respect to future research. |
| Audience | Academic |
| Author | Shen, Ting Mirzaei, Mehdi Graham, Stuart L. You, Yuyi Klistorner, Alexander Gupta, Vivek Joseph, Chitra |
| AuthorAffiliation | 2 Save Sight Institute, Sydney University, Sydney, Australia 3 Faculty of Science and Engineering, Macquarie University, Australia 1 Faculty of Medicine and Health Sciences, Macquarie University, Australia |
| AuthorAffiliation_xml | – name: 1 Faculty of Medicine and Health Sciences, Macquarie University, Australia – name: 3 Faculty of Science and Engineering, Macquarie University, Australia – name: 2 Save Sight Institute, Sydney University, Sydney, Australia |
| Author_xml | – sequence: 1 givenname: Ting surname: Shen fullname: Shen, Ting – sequence: 2 givenname: Yuyi surname: You fullname: You, Yuyi – sequence: 3 givenname: Chitra surname: Joseph fullname: Joseph, Chitra – sequence: 4 givenname: Mehdi surname: Mirzaei fullname: Mirzaei, Mehdi – sequence: 5 givenname: Alexander surname: Klistorner fullname: Klistorner, Alexander – sequence: 6 givenname: Stuart L. surname: Graham fullname: Graham, Stuart L. – sequence: 7 givenname: Vivek surname: Gupta fullname: Gupta, Vivek |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29896439$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1ksGPEyEUxidmjbuue_RqJjExXloHKNDxYFJbVzfZrMbombyBR4thoAvTmv3vpXbdtEbhAIHf98HL-55WJyEGrKrnpBmTCWPizWwxpg2R40YS-ag6o4TTEae8OTnYn1YXOf9oymAtZS17Up3SdtqKCWvPKv1-cXNZf4n-ro9pvXK5f1vP6q-4dfizjra-GnK9cLAMMQ9O1xBMPfcuOA2-UB63EDTWLtQ3uEnR4BIDJhjcFossx2Qw5WfVYws-48X9el59v_zwbf5pdP3549V8dj3SnJNhpDtCAbjtOgNsYo0wAqS1rWmsACFpN5XQddhxiZZxQoSxsmVGak0NwJSx8-rd3ne96Xo0GsOQwKt1cj2kOxXBqeOb4FZqGbeKt9OpaEQxeH1vkOLtBvOgepc1eg8B4yYr2vBJSyVpJwV9uUeX4FG5YGNx1DtczTgXRArBZaHG_6DKNNg7XXppXTk_Erw6EKwQ_LDK0W8GF0M-Bl8c1vpQ5J_OFmC0B3SKOSe0Dwhp1O_wqNlC7cKjduEpPPuL126A3bvly87_R_ULcofGug |
| CitedBy_id | crossref_primary_10_1167_iovs_18_26364 crossref_primary_10_1371_journal_pone_0291397 crossref_primary_10_1007_s00441_020_03253_2 crossref_primary_10_3389_fphys_2023_1102526 crossref_primary_10_1097_MD_0000000000028910 crossref_primary_10_1186_s13568_024_01664_w crossref_primary_10_1097_MD_0000000000029481 crossref_primary_10_1186_s12885_025_14430_3 crossref_primary_10_3389_fnins_2019_01236 crossref_primary_10_3390_genes13020332 crossref_primary_10_3390_ijms23158417 crossref_primary_10_7759_cureus_74048 crossref_primary_10_1016_j_taap_2019_114673 crossref_primary_10_3390_ijms22041758 crossref_primary_10_1080_1028415X_2023_2245996 crossref_primary_10_3389_fphys_2021_686838 crossref_primary_10_1186_s13568_023_01640_w crossref_primary_10_1038_s41531_024_00771_6 crossref_primary_10_19163_2307_9266_2025_13_1_4_19 crossref_primary_10_1177_02698811211032609 crossref_primary_10_3390_genes13081336 crossref_primary_10_3390_ijms23148011 crossref_primary_10_1007_s10517_019_04574_1 crossref_primary_10_1007_s12311_021_01313_z crossref_primary_10_3390_genes15020240 crossref_primary_10_15446_revfacmed_v69n3_80142 crossref_primary_10_3233_JAD_180853 crossref_primary_10_3390_life15020213 crossref_primary_10_1177_1178646920978243 crossref_primary_10_1167_iovs_64_12_9 crossref_primary_10_3390_genes14122130 crossref_primary_10_1038_s41598_020_77210_y crossref_primary_10_3389_fgene_2018_00583 crossref_primary_10_3389_fphar_2020_00077 crossref_primary_10_1016_j_neulet_2022_136478 crossref_primary_10_1007_s10072_023_07173_1 crossref_primary_10_1016_j_jad_2021_10_077 crossref_primary_10_3389_fnmol_2021_638176 crossref_primary_10_1016_j_bbr_2021_113712 crossref_primary_10_1177_11206721251335060 crossref_primary_10_1016_j_jsbmb_2023_106356 crossref_primary_10_1016_j_nicl_2023_103329 crossref_primary_10_1007_s12035_021_02627_z crossref_primary_10_1080_01616412_2021_1922181 crossref_primary_10_1016_j_neulet_2019_134653 crossref_primary_10_3233_JAD_190738 crossref_primary_10_3390_ijms22073582 crossref_primary_10_1016_j_janxdis_2020_102223 crossref_primary_10_3390_ijms26188987 crossref_primary_10_1007_s11064_019_02910_5 crossref_primary_10_3389_fendo_2024_1417292 crossref_primary_10_1038_s41531_024_00803_1 crossref_primary_10_1016_j_envres_2021_110727 crossref_primary_10_3390_ijms232314599 crossref_primary_10_1016_j_phrs_2020_105281 crossref_primary_10_3389_fpsyg_2024_1386233 crossref_primary_10_4103_1673_5374_343894 crossref_primary_10_1155_2019_3124295 crossref_primary_10_1016_j_expneurol_2021_113891 crossref_primary_10_1111_gbb_12724 crossref_primary_10_1016_j_blre_2021_100871 crossref_primary_10_1186_s12888_021_03081_w crossref_primary_10_14814_phy2_16140 crossref_primary_10_1016_j_bios_2025_117837 crossref_primary_10_3390_ijms21186524 crossref_primary_10_1155_2021_7117613 crossref_primary_10_3389_fneur_2024_1385042 crossref_primary_10_3389_fpsyt_2022_1022442 crossref_primary_10_1152_jn_00268_2021 crossref_primary_10_3389_fnagi_2023_1244191 crossref_primary_10_3390_genes13030482 crossref_primary_10_3390_diagnostics10090684 crossref_primary_10_3390_jpm13091395 crossref_primary_10_1093_arclin_acae014 crossref_primary_10_1016_j_jneuroim_2020_577406 crossref_primary_10_1016_j_pnpbp_2019_109657 crossref_primary_10_1016_j_msard_2021_103033 crossref_primary_10_1186_s40035_023_00341_5 crossref_primary_10_3389_fnins_2021_715330 crossref_primary_10_1016_j_preteyeres_2020_100899 crossref_primary_10_3389_fphys_2025_1568334 crossref_primary_10_1016_j_brainres_2020_146652 crossref_primary_10_1016_j_neulet_2019_05_002 crossref_primary_10_1080_13854046_2020_1740324 crossref_primary_10_1089_ars_2020_8075 crossref_primary_10_1097_YCT_0000000000001123 crossref_primary_10_1016_j_bbr_2020_113081 crossref_primary_10_1016_j_biochi_2019_02_011 crossref_primary_10_1016_j_bbr_2019_112039 crossref_primary_10_1186_s42358_021_00183_7 |
| Cites_doi | 10.1159/000075332 10.1002/ajmg.b.30986 10.1002/(SICI)1096-9861(19970915)386:1<149::AID-CNE13>3.0.CO;2-F 10.1016/j.bbadis.2014.05.026 10.1001/archgenpsychiatry.2010.194 10.1523/JNEUROSCI.12-11-04391.1992 10.1002/ana.10585 10.1007/s100720170011 10.1038/ng.2390 10.1016/j.jneuroim.2005.06.008 10.1006/bbrc.1999.1561 10.1212/01.wnl.0000187075.81589.fd 10.1007/s00415-005-0667-5 10.1126/science.7638622 10.3389/fneur.2017.00159 10.1038/381706a0 10.1016/j.ygeno.2007.05.004 10.1523/JNEUROSCI.2680-04.2004 10.1093/brain/awh624 10.1002/ajmg.b.30332 10.3325/cmj.2009.50.43 10.1007/s00702-004-0210-3 10.1016/j.brainresbull.2009.06.022 10.1371/journal.pone.0086498 10.1016/0888-7543(91)90436-I 10.1016/0304-3940(94)11123-Z 10.1038/ng.396 10.1016/j.biopsych.2005.09.022 10.3758/CABN.6.1.79 10.1136/bjo.2005.081224 10.1002/ana.10842 10.1016/j.pnpbp.2011.02.009 10.1017/S0317167100047351 10.1016/S0092-8674(03)00035-7 10.2165/11595870-000000000-00000 10.1038/349704a0 10.1016/j.neuropsychologia.2012.09.042 10.1002/ajmg.b.30154 10.1152/physrev.2001.81.2.741 10.1016/j.pathophys.2010.04.006 10.1016/j.neulet.2005.11.032 10.1007/s10072-010-0433-z 10.1016/j.preteyeres.2010.02.001 10.1002/ajmg.b.30476 10.1016/j.pnpbp.2008.03.014 10.1097/YPG.0b013e32833a2038 10.1038/sj.mp.4000792 10.1001/archneur.57.6.846 10.1093/hmg/ddr120 10.1523/JNEUROSCI.3501-13.2014 10.5114/aoms.2014.45089 10.55782/ane-2010-1816 10.1371/journal.pone.0115579 10.1002/ana.10079 10.1111/j.1600-0404.2009.01253.x 10.1073/pnas.92.19.8856 10.1016/j.jneuroim.2007.10.013 10.1038/361031a0 10.1002/mds.20491 10.1111/ene.12913 10.1016/j.neulet.2003.09.009 10.1371/journal.pone.0061063 10.1038/mp.2015.27 10.1007/s00415-005-0756-5 10.1007/s00415-009-5357-2 10.1056/NEJMoa073493 10.1016/j.neurobiolaging.2005.10.013 10.1016/S1474-4422(03)00308-9 10.1016/j.neuroimage.2012.08.079 10.1126/science.1129663 10.1136/jnnp.2008.154294 10.1016/j.neulet.2005.02.017 10.1159/000336997 10.1073/pnas.91.5.1632 10.1038/nature02621 10.1093/brain/aww200 10.1016/j.jocn.2011.03.015 10.1056/NEJM199304153281507 10.1111/j.1601-183X.2007.00363.x 10.1074/jbc.M008104200 10.1038/mp.2009.24 10.1126/science.2321006 10.1016/j.neulet.2006.12.038 10.1006/exnr.2000.7483 10.1126/science.275.5300.668 10.1016/j.brainres.2008.11.047 10.1016/j.neulet.2016.01.030 10.1159/000077736 10.1002/ajmg.b.20118 10.1101/gr.8.8.769 10.1212/WNL.0000000000000768 10.1038/376775a0 10.1016/j.neurobiolaging.2013.05.006 10.1016/j.parkreldis.2003.12.003 10.1371/journal.pone.0010003 10.1016/0896-6273(91)90273-3 10.1016/j.neulet.2013.12.051 10.1111/j.1468-1331.2009.02706.x 10.1016/j.expneurol.2005.01.026 10.1007/s00406-011-0189-3 10.1016/j.jalz.2007.04.381 10.1016/j.neurobiolaging.2014.08.023 10.1242/jcs.033316 10.1515/CCLM.2011.039 10.1016/S0006-3223(03)00181-1 10.1016/j.bbr.2009.10.022 10.1093/hmg/ddm189 10.1016/j.pathophys.2010.04.005 10.1176/appi.ajp.161.11.1957 10.1038/sj.tpj.6500094 10.1038/sj.mp.4000952 10.1016/S0006-8993(00)02237-X 10.1098/rstb.2006.1894 10.1016/j.jneuroim.2012.01.011 10.1038/mp.2008.80 10.1038/sj.mp.4001799 10.1093/cercor/bhw020 10.1002/ana.10487 10.1093/emboj/16.16.4999 10.1111/j.1601-183X.2006.00245.x 10.1146/annurev.genom.2.1.235 10.1111/j.1468-1331.2011.03529.x 10.1016/S0304-3940(01)01830-4 10.1006/exnr.2002.7869 10.1016/j.neulet.2005.07.009 10.1167/iovs.02-1332 10.1016/j.pharmthera.2013.01.004 10.1016/S0304-3940(99)00463-2 10.3389/neuro.09.011.2008 10.1126/science.1066901 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2018 JKL International Copyright: © 2018 Shen et al. 2018 |
| Copyright_xml | – notice: COPYRIGHT 2018 JKL International – notice: Copyright: © 2018 Shen et al. 2018 |
| DBID | AAYXX CITATION NPM 7X8 5PM |
| DOI | 10.14336/AD.2017.0717 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology |
| EISSN | 2152-5250 |
| EndPage | 536 |
| ExternalDocumentID | PMC5988606 A556176657 29896439 10_14336_AD_2017_0717 |
| Genre | Journal Article Review |
| GroupedDBID | 53G 5VS AAYXX ABDBF ACUHS ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV C1A CITATION DIK EBD ESX GROUPED_DOAJ HYE IAO IHR IHW ITC KQ8 M~E OK1 RPM TUS NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c551t-cb12aa5fbbda34fd6d6a7ff9d0f6a672b87abbeb57ef35116df793d7cc2daa833 |
| ISICitedReferencesCount | 110 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000434762200017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2152-5250 |
| IngestDate | Thu Aug 21 13:37:29 EDT 2025 Fri Jul 11 09:25:15 EDT 2025 Wed Mar 19 01:50:54 EDT 2025 Sat Mar 08 18:13:57 EST 2025 Thu May 22 21:21:37 EDT 2025 Wed Feb 19 02:43:01 EST 2025 Tue Nov 18 22:05:31 EST 2025 Sat Nov 29 06:32:53 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | neurodegenerative diseases polymorphism Alzheimer’s disease BDNF glaucoma multiple sclerosis |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c551t-cb12aa5fbbda34fd6d6a7ff9d0f6a672b87abbeb57ef35116df793d7cc2daa833 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | http://dx.doi.org/10.14336/AD.2017.0717 |
| PMID | 29896439 |
| PQID | 2054927194 |
| PQPubID | 23479 |
| PageCount | 14 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5988606 proquest_miscellaneous_2054927194 gale_infotracmisc_A556176657 gale_infotracacademiconefile_A556176657 gale_healthsolutions_A556176657 pubmed_primary_29896439 crossref_primary_10_14336_AD_2017_0717 crossref_citationtrail_10_14336_AD_2017_0717 |
| PublicationCentury | 2000 |
| PublicationDate | 2018-06-01 |
| PublicationDateYYYYMMDD | 2018-06-01 |
| PublicationDate_xml | – month: 06 year: 2018 text: 2018-06-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Aging and disease |
| PublicationTitleAlternate | Aging Dis |
| PublicationYear | 2018 |
| Publisher | JKL International JKL International LLC |
| Publisher_xml | – name: JKL International – name: JKL International LLC |
| References | key-10.14336/AD.2017.0717-50 key-10.14336/AD.2017.0717-49 key-10.14336/AD.2017.0717-48 key-10.14336/AD.2017.0717-45 key-10.14336/AD.2017.0717-44 key-10.14336/AD.2017.0717-47 key-10.14336/AD.2017.0717-46 key-10.14336/AD.2017.0717-41 key-10.14336/AD.2017.0717-40 key-10.14336/AD.2017.0717-43 key-10.14336/AD.2017.0717-42 key-10.14336/AD.2017.0717-3 key-10.14336/AD.2017.0717-2 key-10.14336/AD.2017.0717-1 key-10.14336/AD.2017.0717-38 key-10.14336/AD.2017.0717-37 key-10.14336/AD.2017.0717-39 key-10.14336/AD.2017.0717-7 key-10.14336/AD.2017.0717-34 key-10.14336/AD.2017.0717-6 key-10.14336/AD.2017.0717-33 key-10.14336/AD.2017.0717-5 key-10.14336/AD.2017.0717-36 key-10.14336/AD.2017.0717-4 key-10.14336/AD.2017.0717-35 key-10.14336/AD.2017.0717-30 key-10.14336/AD.2017.0717-9 key-10.14336/AD.2017.0717-32 key-10.14336/AD.2017.0717-8 key-10.14336/AD.2017.0717-31 key-10.14336/AD.2017.0717-70 key-10.14336/AD.2017.0717-72 key-10.14336/AD.2017.0717-71 key-10.14336/AD.2017.0717-67 key-10.14336/AD.2017.0717-135 key-10.14336/AD.2017.0717-66 key-10.14336/AD.2017.0717-134 key-10.14336/AD.2017.0717-69 key-10.14336/AD.2017.0717-133 key-10.14336/AD.2017.0717-68 key-10.14336/AD.2017.0717-132 key-10.14336/AD.2017.0717-63 key-10.14336/AD.2017.0717-131 key-10.14336/AD.2017.0717-62 key-10.14336/AD.2017.0717-130 key-10.14336/AD.2017.0717-65 key-10.14336/AD.2017.0717-64 key-10.14336/AD.2017.0717-61 key-10.14336/AD.2017.0717-60 key-10.14336/AD.2017.0717-129 key-10.14336/AD.2017.0717-128 key-10.14336/AD.2017.0717-127 key-10.14336/AD.2017.0717-126 key-10.14336/AD.2017.0717-125 key-10.14336/AD.2017.0717-59 key-10.14336/AD.2017.0717-56 key-10.14336/AD.2017.0717-124 key-10.14336/AD.2017.0717-55 key-10.14336/AD.2017.0717-123 key-10.14336/AD.2017.0717-58 key-10.14336/AD.2017.0717-122 key-10.14336/AD.2017.0717-57 key-10.14336/AD.2017.0717-121 key-10.14336/AD.2017.0717-52 key-10.14336/AD.2017.0717-120 key-10.14336/AD.2017.0717-51 key-10.14336/AD.2017.0717-54 key-10.14336/AD.2017.0717-53 key-10.14336/AD.2017.0717-92 key-10.14336/AD.2017.0717-91 key-10.14336/AD.2017.0717-94 key-10.14336/AD.2017.0717-119 key-10.14336/AD.2017.0717-93 key-10.14336/AD.2017.0717-118 key-10.14336/AD.2017.0717-117 key-10.14336/AD.2017.0717-116 key-10.14336/AD.2017.0717-90 key-10.14336/AD.2017.0717-115 key-10.14336/AD.2017.0717-114 key-10.14336/AD.2017.0717-89 key-10.14336/AD.2017.0717-113 key-10.14336/AD.2017.0717-88 key-10.14336/AD.2017.0717-112 key-10.14336/AD.2017.0717-111 key-10.14336/AD.2017.0717-110 key-10.14336/AD.2017.0717-85 key-10.14336/AD.2017.0717-84 key-10.14336/AD.2017.0717-87 key-10.14336/AD.2017.0717-86 key-10.14336/AD.2017.0717-81 key-10.14336/AD.2017.0717-80 key-10.14336/AD.2017.0717-109 key-10.14336/AD.2017.0717-83 key-10.14336/AD.2017.0717-108 key-10.14336/AD.2017.0717-82 key-10.14336/AD.2017.0717-107 key-10.14336/AD.2017.0717-106 key-10.14336/AD.2017.0717-105 key-10.14336/AD.2017.0717-104 key-10.14336/AD.2017.0717-103 key-10.14336/AD.2017.0717-78 key-10.14336/AD.2017.0717-102 key-10.14336/AD.2017.0717-77 key-10.14336/AD.2017.0717-101 key-10.14336/AD.2017.0717-100 key-10.14336/AD.2017.0717-79 key-10.14336/AD.2017.0717-74 key-10.14336/AD.2017.0717-73 key-10.14336/AD.2017.0717-76 key-10.14336/AD.2017.0717-75 key-10.14336/AD.2017.0717-27 key-10.14336/AD.2017.0717-26 key-10.14336/AD.2017.0717-29 key-10.14336/AD.2017.0717-28 key-10.14336/AD.2017.0717-23 key-10.14336/AD.2017.0717-22 key-10.14336/AD.2017.0717-25 key-10.14336/AD.2017.0717-24 key-10.14336/AD.2017.0717-21 key-10.14336/AD.2017.0717-20 key-10.14336/AD.2017.0717-19 key-10.14336/AD.2017.0717-16 key-10.14336/AD.2017.0717-15 key-10.14336/AD.2017.0717-18 key-10.14336/AD.2017.0717-17 key-10.14336/AD.2017.0717-12 key-10.14336/AD.2017.0717-11 key-10.14336/AD.2017.0717-99 key-10.14336/AD.2017.0717-14 key-10.14336/AD.2017.0717-13 key-10.14336/AD.2017.0717-96 key-10.14336/AD.2017.0717-95 key-10.14336/AD.2017.0717-10 key-10.14336/AD.2017.0717-98 key-10.14336/AD.2017.0717-97 15772739 - J Neurol. 2005 Jul;252(7):833-8 18977816 - J Neurol Neurosurg Psychiatry. 2009 Feb;80(2):141-4 19156154 - Mol Psychiatry. 2009 Feb;14(2):120-2 19874854 - Behav Brain Res. 2010 Mar 5;207(2):377-86 19050044 - J Cell Sci. 2009 Jan 1;122(Pt 1):36-43 19538209 - Eur J Neurol. 2009 Nov;16(11):1240-5 16442082 - Biol Psychiatry. 2006 May 1;59(9):812-5 11922662 - Exp Neurol. 2002 Apr;174(2):201-14 11274073 - Invest Ophthalmol Vis Sci. 2001 Apr;42(5):966-74 19847468 - J Neurol. 2010 Apr;257(4):540-5 11840305 - Mol Psychiatry. 2002;7(2):136-7 25444596 - Neurobiol Aging. 2015 Mar;36(3):1605.e1-6 16446742 - Mol Psychiatry. 2006 May;11(5):505-13 11701650 - Annu Rev Genomics Hum Genet. 2001;2:235-58 16488940 - Br J Ophthalmol. 2006 Mar;90(3):262-7 15635706 - Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134B(1):1-5 1742020 - Neuron. 1991 Nov;7(5):695-702 17023662 - Science. 2006 Oct 6;314(5796):140-3 26806863 - Neurosci Lett. 2016 Feb 26;615:88-91 17427185 - Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):458-62 21196952 - Acta Neurobiol Exp (Wars). 2010;70(4):454-67 24942931 - Biochim Biophys Acta. 2014 Sep;1842(9):1567-78 21967235 - Eur J Neurol. 2012 Apr;19(4):655-9 20400928 - Psychiatr Genet. 2010 Jun;20(3):109-12 28507530 - Front Neurol. 2017 May 01;8:159 10454142 - Neurosci Lett. 1999 Jul 23;270(1):45-8 18061279 - J Neuroimmunol. 2008 Jan;193(1-2):170-2 1432101 - J Neurosci. 1992 Nov;12(11):4391-402 24523553 - J Neurosci. 2014 Feb 12;34(7):2645-51 2321006 - Science. 1990 Mar 23;247(4949 Pt 1):1446-51 15726264 - J Neurol. 2005 Apr;252(4):423-8 23593393 - PLoS One. 2013 Apr 11;8(4):e61063 11376903 - Neurosci Lett. 2001 Jun 8;305(2):139-42 23769397 - Neurobiol Aging. 2013 Nov;34(11):2457-64 21143020 - Clin Chem Lab Med. 2011 Feb;49(2):185-9 17229524 - Neurosci Lett. 2007 Mar 19;415(1):59-63 16344533 - Neurology. 2005 Dec 13;65(11):1823-5 15048661 - Am J Med Genet B Neuropsychiatr Genet. 2004 Apr 1;126B(1):122-3 21290143 - Eur Arch Psychiatry Clin Neurosci. 2011 Aug;261(5):323-9 21985169 - Drugs. 2011 Oct 22;71(15):2031-65 8421494 - Nature. 1993 Jan 7;361(6407):31-9 7568031 - Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8856-60 1671712 - Nature. 1991 Feb 21;349(6311):704-6 11782995 - Ann Neurol. 2002 Jan;51(1):133-6 20478698 - Pathophysiology. 2011 Feb;18(1):53-60 17656372 - Hum Mol Genet. 2007 Nov 15;16(22):2659-68 12783434 - Ann Neurol. 2003 Jun;53(6):823 12049172 - Pharmacogenomics J. 2002;2(2):103-10 16046000 - J Neuroimmunol. 2005 Oct;167(1-2):183-5 20953813 - Neurol Sci. 2011 Feb;32(1):117-23 8455668 - N Engl J Med. 1993 Apr 15;328(15):1097-106 15537879 - J Neurosci. 2004 Nov 10;24(45):10099-102 17629449 - Genomics. 2007 Sep;90(3):397-406 16054753 - Neurosci Lett. 2005 Oct 14;387(1):11-6 16740142 - Genes Brain Behav. 2007 Mar;6(2):177-83 16356643 - Neurosci Lett. 2006 Apr 3;396(3):217-9 15838855 - Mov Disord. 2005 Aug;20(8):1031-3 8127857 - Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1632-6 9303531 - J Comp Neurol. 1997 Sep 15;386(1):149-60 25536045 - PLoS One. 2014 Dec 23;9(12):e115579 19595937 - Alzheimers Dement. 2007 Jul;3(3):186-91 14730194 - Neuropsychobiology. 2004;49(1):10-2 19504537 - Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):235-42 25824305 - Mol Psychiatry. 2015 Aug;20(8):916-30 12666095 - Ann Neurol. 2003;53 Suppl 3:S16-23; discussion S23-5 10711692 - Invest Ophthalmol Vis Sci. 2000 Mar;41(3):764-74 15571060 - Am Fam Physician. 2004 Nov 15;70(10):1935-44 16869232 - Cogn Affect Behav Neurosci. 2006 Mar;6(1):79-85 20547043 - Pathophysiology. 2011 Feb;18(1):43-52 12842310 - Biol Psychiatry. 2003 Jul 1;54(1):70-5 16565926 - Folia Neuropathol. 2006;44(1):12-6 25200713 - Neurology. 2014 Sep 9;83(11):1022-4 8467424 - Can J Neurol Sci. 1993 Feb;20(1):17-29 15375678 - J Neural Transm (Vienna). 2005 May;112(5):703-11 11834836 - Science. 2002 Feb 8;295(5557):1077-9 9724323 - Genome Res. 1998 Aug;8(8):769-76 9005853 - Science. 1997 Jan 31;275(5300):668-70 19260143 - Croat Med J. 2009 Feb;50(1):43-8 21427129 - Hum Mol Genet. 2011 Jun 15;20(12):2464-71 14507880 - Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4357-65 18472202 - Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1236-42 27521573 - Brain. 2016 Oct;139(Pt 10):2766-2777 14991827 - Ann Neurol. 2004 Mar;55(3):447-8 24394906 - Neurosci Lett. 2014 Feb 21;561:86-90 19589373 - Brain Res Bull. 2010 Jan 15;81(1):61-5 15514393 - Am J Psychiatry. 2004 Nov;161(11):1957-66 11152678 - J Biol Chem. 2001 Apr 20;276(16):12660-6 16649215 - Am J Med Genet B Neuropsychiatr Genet. 2006 Jun 5;141B(4):387-93 18958211 - Front Hum Neurosci. 2008 Sep 23;2:11 26830347 - Cereb Cortex. 2016 Apr;26(4):1795-803 20368992 - PLoS One. 2010 Apr 02;5(4):e10003 15896483 - Neurosci Lett. 2005 Jun 24;381(3):275-8 26756166 - Eur J Neurol. 2016 Mar;23 (3):630-40 10825501 - Brain Res. 2000 Jun 2;866(1-2):257-61 20085561 - Acta Neurol Scand. 2010 Jul;122(1):41-5 12553913 - Cell. 2003 Jan 24;112(2):257-69 23348013 - Pharmacol Ther. 2013 May;138(2):155-75 7638622 - Science. 1995 Aug 18;269(5226):973-7 22341604 - J Neuroimmunol. 2012 Mar;244(1-2):107-10 14642442 - Neurosci Lett. 2003 Dec 15;353(1):75-7 16183661 - Brain. 2005 Dec;128(Pt 12):2899-910 19255578 - Mol Psychiatry. 2010 Aug;15(8):810-5 8649517 - Nature. 1996 Jun 20;381(6584):706-9 19071096 - Brain Res. 2009 Feb 23;1256:123-8 23041465 - Neuropsychologia. 2012 Dec;50(14):3554-63 11274343 - Physiol Rev. 2001 Apr;81(2):741-66 19525955 - Nat Genet. 2009 Jul;41(7):824-8 22922875 - Nat Genet. 2012 Oct;44(10 ):1142-1146 17660530 - N Engl J Med. 2007 Aug 30;357(9):851-62 22001244 - J Clin Neurosci. 2011 Dec;18(12):1744-5 24475133 - PLoS One. 2014 Jan 27;9(1):e86498 11603614 - Neurol Sci. 2001 Apr;22(2):117-39 12849268 - Lancet Neurol. 2003 Feb;2(2):117-27 7651536 - Nature. 1995 Aug 31;376(6543):775-8 22963854 - Neuroimage. 2013 Jan 1;64:290-8 22538247 - Neuropsychobiology. 2012 Jun;65(4):183-7 15120095 - Parkinsonism Relat Disord. 2004 Jun;10(4):213-9 1889806 - Genomics. 1991 Jul;10(3):558-68 10867782 - Arch Neurol. 2000 Jun;57(6):846-51 21338649 - Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):1022-5 7746496 - Neurosci Lett. 1995 Jan 2;183(1-2):96-9 16939974 - Philos Trans R Soc Lond B Biol Sci. 2006 Sep 29;361(1473):1545-64 17973920 - Genes Brain Behav. 2008 Jun;7(4):411-7 9305641 - EMBO J. 1997 Aug 15;16(16):4999-5005 21300947 - Arch Gen Psychiatry. 2011 Feb;68(2):198-206 15295589 - Nature. 2004 Aug 5;430(7000):631-9 11244490 - Mol Psychiatry. 2001 Jan;6(1):83-6 15899246 - Exp Neurol. 2005 Jul;194(1):91-6 15084795 - Dement Geriatr Cogn Disord. 2004;18(1):55-8 11031089 - Exp Neurol. 2000 Nov;166(1):127-35 25624860 - Arch Med Sci. 2014 Dec 22;10(6):1206-13 16343697 - Neurobiol Aging. 2006 Dec;27(12):1834-7 20226873 - Prog Retin Eye Res. 2010 Jul;29(4):249-71 10543986 - Biochem Biophys Res Commun. 1999 Nov 2;264(3):648-51 |
| References_xml | – ident: key-10.14336/AD.2017.0717-104 doi: 10.1159/000075332 – ident: key-10.14336/AD.2017.0717-41 doi: 10.1002/ajmg.b.30986 – ident: key-10.14336/AD.2017.0717-65 doi: 10.1002/(SICI)1096-9861(19970915)386:1<149::AID-CNE13>3.0.CO;2-F – ident: key-10.14336/AD.2017.0717-69 doi: 10.1016/j.bbadis.2014.05.026 – ident: key-10.14336/AD.2017.0717-131 doi: 10.1001/archgenpsychiatry.2010.194 – ident: key-10.14336/AD.2017.0717-18 doi: 10.1523/JNEUROSCI.12-11-04391.1992 – ident: key-10.14336/AD.2017.0717-120 doi: 10.1002/ana.10585 – ident: key-10.14336/AD.2017.0717-89 doi: 10.1007/s100720170011 – ident: key-10.14336/AD.2017.0717-19 – ident: key-10.14336/AD.2017.0717-63 doi: 10.1038/ng.2390 – ident: key-10.14336/AD.2017.0717-86 doi: 10.1016/j.jneuroim.2005.06.008 – ident: key-10.14336/AD.2017.0717-8 doi: 10.1006/bbrc.1999.1561 – ident: key-10.14336/AD.2017.0717-114 doi: 10.1212/01.wnl.0000187075.81589.fd – ident: key-10.14336/AD.2017.0717-75 – ident: key-10.14336/AD.2017.0717-42 doi: 10.1007/s00415-005-0667-5 – ident: key-10.14336/AD.2017.0717-98 doi: 10.1126/science.7638622 – ident: key-10.14336/AD.2017.0717-30 doi: 10.3389/fneur.2017.00159 – ident: key-10.14336/AD.2017.0717-14 doi: 10.1038/381706a0 – ident: key-10.14336/AD.2017.0717-21 doi: 10.1016/j.ygeno.2007.05.004 – ident: key-10.14336/AD.2017.0717-53 doi: 10.1523/JNEUROSCI.2680-04.2004 – ident: key-10.14336/AD.2017.0717-91 doi: 10.1093/brain/awh624 – ident: key-10.14336/AD.2017.0717-34 doi: 10.1002/ajmg.b.30332 – ident: key-10.14336/AD.2017.0717-33 doi: 10.3325/cmj.2009.50.43 – ident: key-10.14336/AD.2017.0717-43 doi: 10.1007/s00702-004-0210-3 – ident: key-10.14336/AD.2017.0717-49 doi: 10.1016/j.brainresbull.2009.06.022 – ident: key-10.14336/AD.2017.0717-100 doi: 10.1371/journal.pone.0086498 – ident: key-10.14336/AD.2017.0717-4 doi: 10.1016/0888-7543(91)90436-I – ident: key-10.14336/AD.2017.0717-64 doi: 10.1016/0304-3940(94)11123-Z – ident: key-10.14336/AD.2017.0717-77 doi: 10.1038/ng.396 – ident: key-10.14336/AD.2017.0717-133 doi: 10.1016/j.biopsych.2005.09.022 – ident: key-10.14336/AD.2017.0717-31 doi: 10.3758/CABN.6.1.79 – ident: key-10.14336/AD.2017.0717-59 doi: 10.1136/bjo.2005.081224 – ident: key-10.14336/AD.2017.0717-106 doi: 10.1002/ana.10842 – ident: key-10.14336/AD.2017.0717-51 doi: 10.1016/j.pnpbp.2011.02.009 – ident: key-10.14336/AD.2017.0717-88 doi: 10.1017/S0317167100047351 – ident: key-10.14336/AD.2017.0717-1 doi: 10.1016/S0092-8674(03)00035-7 – ident: key-10.14336/AD.2017.0717-95 doi: 10.2165/11595870-000000000-00000 – ident: key-10.14336/AD.2017.0717-96 doi: 10.1038/349704a0 – ident: key-10.14336/AD.2017.0717-129 doi: 10.1016/j.neuropsychologia.2012.09.042 – ident: key-10.14336/AD.2017.0717-40 doi: 10.1002/ajmg.b.30154 – ident: key-10.14336/AD.2017.0717-99 doi: 10.1152/physrev.2001.81.2.741 – ident: key-10.14336/AD.2017.0717-81 doi: 10.1016/j.pathophys.2010.04.006 – ident: key-10.14336/AD.2017.0717-87 doi: 10.1016/j.neulet.2005.11.032 – ident: key-10.14336/AD.2017.0717-83 doi: 10.1007/s10072-010-0433-z – ident: key-10.14336/AD.2017.0717-58 doi: 10.1016/j.preteyeres.2010.02.001 – ident: key-10.14336/AD.2017.0717-122 doi: 10.1002/ajmg.b.30476 – ident: key-10.14336/AD.2017.0717-134 doi: 10.1016/j.pnpbp.2008.03.014 – ident: key-10.14336/AD.2017.0717-25 doi: 10.1097/YPG.0b013e32833a2038 – ident: key-10.14336/AD.2017.0717-108 doi: 10.1038/sj.mp.4000792 – ident: key-10.14336/AD.2017.0717-7 doi: 10.1001/archneur.57.6.846 – ident: key-10.14336/AD.2017.0717-62 doi: 10.1093/hmg/ddr120 – ident: key-10.14336/AD.2017.0717-135 doi: 10.1523/JNEUROSCI.3501-13.2014 – ident: key-10.14336/AD.2017.0717-72 doi: 10.5114/aoms.2014.45089 – ident: key-10.14336/AD.2017.0717-66 – ident: key-10.14336/AD.2017.0717-17 doi: 10.55782/ane-2010-1816 – ident: key-10.14336/AD.2017.0717-70 doi: 10.1371/journal.pone.0115579 – ident: key-10.14336/AD.2017.0717-113 doi: 10.1002/ana.10079 – ident: key-10.14336/AD.2017.0717-126 doi: 10.1111/j.1600-0404.2009.01253.x – ident: key-10.14336/AD.2017.0717-15 doi: 10.1073/pnas.92.19.8856 – ident: key-10.14336/AD.2017.0717-38 doi: 10.1016/j.jneuroim.2007.10.013 – ident: key-10.14336/AD.2017.0717-13 doi: 10.1038/361031a0 – ident: key-10.14336/AD.2017.0717-103 doi: 10.1002/mds.20491 – ident: key-10.14336/AD.2017.0717-85 doi: 10.1111/ene.12913 – ident: key-10.14336/AD.2017.0717-121 doi: 10.1016/j.neulet.2003.09.009 – ident: key-10.14336/AD.2017.0717-84 doi: 10.1371/journal.pone.0061063 – ident: key-10.14336/AD.2017.0717-2 doi: 10.1038/mp.2015.27 – ident: key-10.14336/AD.2017.0717-109 doi: 10.1007/s00415-005-0756-5 – ident: key-10.14336/AD.2017.0717-112 doi: 10.1007/s00415-009-5357-2 – ident: key-10.14336/AD.2017.0717-76 doi: 10.1056/NEJMoa073493 – ident: key-10.14336/AD.2017.0717-127 doi: 10.1016/j.neurobiolaging.2005.10.013 – ident: key-10.14336/AD.2017.0717-90 doi: 10.1016/S1474-4422(03)00308-9 – ident: key-10.14336/AD.2017.0717-128 doi: 10.1016/j.neuroimage.2012.08.079 – ident: key-10.14336/AD.2017.0717-46 doi: 10.1126/science.1129663 – ident: key-10.14336/AD.2017.0717-117 doi: 10.1136/jnnp.2008.154294 – ident: key-10.14336/AD.2017.0717-37 doi: 10.1016/j.neulet.2005.02.017 – ident: key-10.14336/AD.2017.0717-52 doi: 10.1159/000336997 – ident: key-10.14336/AD.2017.0717-67 doi: 10.1073/pnas.91.5.1632 – ident: key-10.14336/AD.2017.0717-93 doi: 10.1038/nature02621 – ident: key-10.14336/AD.2017.0717-102 doi: 10.1093/brain/aww200 – ident: key-10.14336/AD.2017.0717-124 doi: 10.1016/j.jocn.2011.03.015 – ident: key-10.14336/AD.2017.0717-57 doi: 10.1056/NEJM199304153281507 – ident: key-10.14336/AD.2017.0717-130 doi: 10.1111/j.1601-183X.2007.00363.x – ident: key-10.14336/AD.2017.0717-6 doi: 10.1074/jbc.M008104200 – ident: key-10.14336/AD.2017.0717-32 doi: 10.1038/mp.2009.24 – ident: key-10.14336/AD.2017.0717-3 doi: 10.1126/science.2321006 – ident: key-10.14336/AD.2017.0717-123 doi: 10.1016/j.neulet.2006.12.038 – ident: key-10.14336/AD.2017.0717-111 doi: 10.1006/exnr.2000.7483 – ident: key-10.14336/AD.2017.0717-60 doi: 10.1126/science.275.5300.668 – ident: key-10.14336/AD.2017.0717-79 doi: 10.1016/j.brainres.2008.11.047 – ident: key-10.14336/AD.2017.0717-116 doi: 10.1016/j.neulet.2016.01.030 – ident: key-10.14336/AD.2017.0717-105 doi: 10.1159/000077736 – ident: key-10.14336/AD.2017.0717-36 doi: 10.1002/ajmg.b.20118 – ident: key-10.14336/AD.2017.0717-28 doi: 10.1101/gr.8.8.769 – ident: key-10.14336/AD.2017.0717-74 doi: 10.1212/WNL.0000000000000768 – ident: key-10.14336/AD.2017.0717-97 doi: 10.1038/376775a0 – ident: key-10.14336/AD.2017.0717-101 doi: 10.1016/j.neurobiolaging.2013.05.006 – ident: key-10.14336/AD.2017.0717-26 doi: 10.1016/j.parkreldis.2003.12.003 – ident: key-10.14336/AD.2017.0717-78 doi: 10.1371/journal.pone.0010003 – ident: key-10.14336/AD.2017.0717-9 doi: 10.1016/0896-6273(91)90273-3 – ident: key-10.14336/AD.2017.0717-125 doi: 10.1016/j.neulet.2013.12.051 – ident: key-10.14336/AD.2017.0717-115 doi: 10.1111/j.1468-1331.2009.02706.x – ident: key-10.14336/AD.2017.0717-107 doi: 10.1016/j.expneurol.2005.01.026 – ident: key-10.14336/AD.2017.0717-48 doi: 10.1007/s00406-011-0189-3 – ident: key-10.14336/AD.2017.0717-94 doi: 10.1016/j.jalz.2007.04.381 – ident: key-10.14336/AD.2017.0717-118 doi: 10.1016/j.neurobiolaging.2014.08.023 – ident: key-10.14336/AD.2017.0717-22 doi: 10.1242/jcs.033316 – ident: key-10.14336/AD.2017.0717-50 doi: 10.1515/CCLM.2011.039 – ident: key-10.14336/AD.2017.0717-12 doi: 10.1016/S0006-3223(03)00181-1 – ident: key-10.14336/AD.2017.0717-23 doi: 10.1016/j.bbr.2009.10.022 – ident: key-10.14336/AD.2017.0717-82 doi: 10.1093/hmg/ddm189 – ident: key-10.14336/AD.2017.0717-39 doi: 10.1016/j.pathophys.2010.04.005 – ident: key-10.14336/AD.2017.0717-132 doi: 10.1176/appi.ajp.161.11.1957 – ident: key-10.14336/AD.2017.0717-27 doi: 10.1038/sj.tpj.6500094 – ident: key-10.14336/AD.2017.0717-35 doi: 10.1038/sj.mp.4000952 – ident: key-10.14336/AD.2017.0717-11 doi: 10.1016/S0006-8993(00)02237-X – ident: key-10.14336/AD.2017.0717-45 doi: 10.1098/rstb.2006.1894 – ident: key-10.14336/AD.2017.0717-44 doi: 10.1016/j.jneuroim.2012.01.011 – ident: key-10.14336/AD.2017.0717-47 doi: 10.1038/mp.2008.80 – ident: key-10.14336/AD.2017.0717-55 doi: 10.1038/sj.mp.4001799 – ident: key-10.14336/AD.2017.0717-73 – ident: key-10.14336/AD.2017.0717-56 doi: 10.1093/cercor/bhw020 – ident: key-10.14336/AD.2017.0717-110 doi: 10.1002/ana.10487 – ident: key-10.14336/AD.2017.0717-119 – ident: key-10.14336/AD.2017.0717-16 doi: 10.1093/emboj/16.16.4999 – ident: key-10.14336/AD.2017.0717-80 doi: 10.1111/j.1601-183X.2006.00245.x – ident: key-10.14336/AD.2017.0717-29 doi: 10.1146/annurev.genom.2.1.235 – ident: key-10.14336/AD.2017.0717-92 doi: 10.1111/j.1468-1331.2011.03529.x – ident: key-10.14336/AD.2017.0717-68 doi: 10.1016/S0304-3940(01)01830-4 – ident: key-10.14336/AD.2017.0717-20 doi: 10.1006/exnr.2002.7869 – ident: key-10.14336/AD.2017.0717-24 doi: 10.1016/j.neulet.2005.07.009 – ident: key-10.14336/AD.2017.0717-71 doi: 10.1167/iovs.02-1332 – ident: key-10.14336/AD.2017.0717-5 doi: 10.1016/j.pharmthera.2013.01.004 – ident: key-10.14336/AD.2017.0717-10 doi: 10.1016/S0304-3940(99)00463-2 – ident: key-10.14336/AD.2017.0717-54 doi: 10.3389/neuro.09.011.2008 – ident: key-10.14336/AD.2017.0717-61 doi: 10.1126/science.1066901 – reference: 16054753 - Neurosci Lett. 2005 Oct 14;387(1):11-6 – reference: 11922662 - Exp Neurol. 2002 Apr;174(2):201-14 – reference: 8127857 - Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1632-6 – reference: 25200713 - Neurology. 2014 Sep 9;83(11):1022-4 – reference: 23593393 - PLoS One. 2013 Apr 11;8(4):e61063 – reference: 25444596 - Neurobiol Aging. 2015 Mar;36(3):1605.e1-6 – reference: 2321006 - Science. 1990 Mar 23;247(4949 Pt 1):1446-51 – reference: 20547043 - Pathophysiology. 2011 Feb;18(1):43-52 – reference: 27521573 - Brain. 2016 Oct;139(Pt 10):2766-2777 – reference: 20478698 - Pathophysiology. 2011 Feb;18(1):53-60 – reference: 11840305 - Mol Psychiatry. 2002;7(2):136-7 – reference: 15537879 - J Neurosci. 2004 Nov 10;24(45):10099-102 – reference: 16869232 - Cogn Affect Behav Neurosci. 2006 Mar;6(1):79-85 – reference: 11274343 - Physiol Rev. 2001 Apr;81(2):741-66 – reference: 21290143 - Eur Arch Psychiatry Clin Neurosci. 2011 Aug;261(5):323-9 – reference: 16565926 - Folia Neuropathol. 2006;44(1):12-6 – reference: 20085561 - Acta Neurol Scand. 2010 Jul;122(1):41-5 – reference: 17656372 - Hum Mol Genet. 2007 Nov 15;16(22):2659-68 – reference: 19504537 - Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):235-42 – reference: 12553913 - Cell. 2003 Jan 24;112(2):257-69 – reference: 8467424 - Can J Neurol Sci. 1993 Feb;20(1):17-29 – reference: 15120095 - Parkinsonism Relat Disord. 2004 Jun;10(4):213-9 – reference: 11834836 - Science. 2002 Feb 8;295(5557):1077-9 – reference: 7746496 - Neurosci Lett. 1995 Jan 2;183(1-2):96-9 – reference: 19255578 - Mol Psychiatry. 2010 Aug;15(8):810-5 – reference: 20368992 - PLoS One. 2010 Apr 02;5(4):e10003 – reference: 24475133 - PLoS One. 2014 Jan 27;9(1):e86498 – reference: 24394906 - Neurosci Lett. 2014 Feb 21;561:86-90 – reference: 24523553 - J Neurosci. 2014 Feb 12;34(7):2645-51 – reference: 19538209 - Eur J Neurol. 2009 Nov;16(11):1240-5 – reference: 16343697 - Neurobiol Aging. 2006 Dec;27(12):1834-7 – reference: 11782995 - Ann Neurol. 2002 Jan;51(1):133-6 – reference: 15048661 - Am J Med Genet B Neuropsychiatr Genet. 2004 Apr 1;126B(1):122-3 – reference: 8649517 - Nature. 1996 Jun 20;381(6584):706-9 – reference: 14991827 - Ann Neurol. 2004 Mar;55(3):447-8 – reference: 22341604 - J Neuroimmunol. 2012 Mar;244(1-2):107-10 – reference: 22963854 - Neuroimage. 2013 Jan 1;64:290-8 – reference: 18061279 - J Neuroimmunol. 2008 Jan;193(1-2):170-2 – reference: 17229524 - Neurosci Lett. 2007 Mar 19;415(1):59-63 – reference: 15514393 - Am J Psychiatry. 2004 Nov;161(11):1957-66 – reference: 17629449 - Genomics. 2007 Sep;90(3):397-406 – reference: 1432101 - J Neurosci. 1992 Nov;12(11):4391-402 – reference: 16488940 - Br J Ophthalmol. 2006 Mar;90(3):262-7 – reference: 16356643 - Neurosci Lett. 2006 Apr 3;396(3):217-9 – reference: 23041465 - Neuropsychologia. 2012 Dec;50(14):3554-63 – reference: 12849268 - Lancet Neurol. 2003 Feb;2(2):117-27 – reference: 1671712 - Nature. 1991 Feb 21;349(6311):704-6 – reference: 24942931 - Biochim Biophys Acta. 2014 Sep;1842(9):1567-78 – reference: 28507530 - Front Neurol. 2017 May 01;8:159 – reference: 16740142 - Genes Brain Behav. 2007 Mar;6(2):177-83 – reference: 20226873 - Prog Retin Eye Res. 2010 Jul;29(4):249-71 – reference: 15084795 - Dement Geriatr Cogn Disord. 2004;18(1):55-8 – reference: 9305641 - EMBO J. 1997 Aug 15;16(16):4999-5005 – reference: 17660530 - N Engl J Med. 2007 Aug 30;357(9):851-62 – reference: 16183661 - Brain. 2005 Dec;128(Pt 12):2899-910 – reference: 15295589 - Nature. 2004 Aug 5;430(7000):631-9 – reference: 10543986 - Biochem Biophys Res Commun. 1999 Nov 2;264(3):648-51 – reference: 16344533 - Neurology. 2005 Dec 13;65(11):1823-5 – reference: 22922875 - Nat Genet. 2012 Oct;44(10 ):1142-1146 – reference: 21967235 - Eur J Neurol. 2012 Apr;19(4):655-9 – reference: 19525955 - Nat Genet. 2009 Jul;41(7):824-8 – reference: 21338649 - Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):1022-5 – reference: 15375678 - J Neural Transm (Vienna). 2005 May;112(5):703-11 – reference: 15838855 - Mov Disord. 2005 Aug;20(8):1031-3 – reference: 22538247 - Neuropsychobiology. 2012 Jun;65(4):183-7 – reference: 19589373 - Brain Res Bull. 2010 Jan 15;81(1):61-5 – reference: 7638622 - Science. 1995 Aug 18;269(5226):973-7 – reference: 10711692 - Invest Ophthalmol Vis Sci. 2000 Mar;41(3):764-74 – reference: 7651536 - Nature. 1995 Aug 31;376(6543):775-8 – reference: 20400928 - Psychiatr Genet. 2010 Jun;20(3):109-12 – reference: 8421494 - Nature. 1993 Jan 7;361(6407):31-9 – reference: 21143020 - Clin Chem Lab Med. 2011 Feb;49(2):185-9 – reference: 15896483 - Neurosci Lett. 2005 Jun 24;381(3):275-8 – reference: 10867782 - Arch Neurol. 2000 Jun;57(6):846-51 – reference: 15726264 - J Neurol. 2005 Apr;252(4):423-8 – reference: 10454142 - Neurosci Lett. 1999 Jul 23;270(1):45-8 – reference: 11701650 - Annu Rev Genomics Hum Genet. 2001;2:235-58 – reference: 19874854 - Behav Brain Res. 2010 Mar 5;207(2):377-86 – reference: 26830347 - Cereb Cortex. 2016 Apr;26(4):1795-803 – reference: 1889806 - Genomics. 1991 Jul;10(3):558-68 – reference: 11603614 - Neurol Sci. 2001 Apr;22(2):117-39 – reference: 21985169 - Drugs. 2011 Oct 22;71(15):2031-65 – reference: 18977816 - J Neurol Neurosurg Psychiatry. 2009 Feb;80(2):141-4 – reference: 15571060 - Am Fam Physician. 2004 Nov 15;70(10):1935-44 – reference: 9724323 - Genome Res. 1998 Aug;8(8):769-76 – reference: 18472202 - Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1236-42 – reference: 16446742 - Mol Psychiatry. 2006 May;11(5):505-13 – reference: 9005853 - Science. 1997 Jan 31;275(5300):668-70 – reference: 14730194 - Neuropsychobiology. 2004;49(1):10-2 – reference: 20953813 - Neurol Sci. 2011 Feb;32(1):117-23 – reference: 25824305 - Mol Psychiatry. 2015 Aug;20(8):916-30 – reference: 11274073 - Invest Ophthalmol Vis Sci. 2001 Apr;42(5):966-74 – reference: 25624860 - Arch Med Sci. 2014 Dec 22;10(6):1206-13 – reference: 12049172 - Pharmacogenomics J. 2002;2(2):103-10 – reference: 16649215 - Am J Med Genet B Neuropsychiatr Genet. 2006 Jun 5;141B(4):387-93 – reference: 9303531 - J Comp Neurol. 1997 Sep 15;386(1):149-60 – reference: 11152678 - J Biol Chem. 2001 Apr 20;276(16):12660-6 – reference: 19260143 - Croat Med J. 2009 Feb;50(1):43-8 – reference: 17427185 - Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):458-62 – reference: 11244490 - Mol Psychiatry. 2001 Jan;6(1):83-6 – reference: 15899246 - Exp Neurol. 2005 Jul;194(1):91-6 – reference: 12842310 - Biol Psychiatry. 2003 Jul 1;54(1):70-5 – reference: 14642442 - Neurosci Lett. 2003 Dec 15;353(1):75-7 – reference: 21300947 - Arch Gen Psychiatry. 2011 Feb;68(2):198-206 – reference: 19156154 - Mol Psychiatry. 2009 Feb;14(2):120-2 – reference: 16046000 - J Neuroimmunol. 2005 Oct;167(1-2):183-5 – reference: 21427129 - Hum Mol Genet. 2011 Jun 15;20(12):2464-71 – reference: 15772739 - J Neurol. 2005 Jul;252(7):833-8 – reference: 14507880 - Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4357-65 – reference: 23348013 - Pharmacol Ther. 2013 May;138(2):155-75 – reference: 21196952 - Acta Neurobiol Exp (Wars). 2010;70(4):454-67 – reference: 17023662 - Science. 2006 Oct 6;314(5796):140-3 – reference: 11031089 - Exp Neurol. 2000 Nov;166(1):127-35 – reference: 19595937 - Alzheimers Dement. 2007 Jul;3(3):186-91 – reference: 19050044 - J Cell Sci. 2009 Jan 1;122(Pt 1):36-43 – reference: 10825501 - Brain Res. 2000 Jun 2;866(1-2):257-61 – reference: 16939974 - Philos Trans R Soc Lond B Biol Sci. 2006 Sep 29;361(1473):1545-64 – reference: 8455668 - N Engl J Med. 1993 Apr 15;328(15):1097-106 – reference: 25536045 - PLoS One. 2014 Dec 23;9(12):e115579 – reference: 17973920 - Genes Brain Behav. 2008 Jun;7(4):411-7 – reference: 18958211 - Front Hum Neurosci. 2008 Sep 23;2:11 – reference: 26806863 - Neurosci Lett. 2016 Feb 26;615:88-91 – reference: 11376903 - Neurosci Lett. 2001 Jun 8;305(2):139-42 – reference: 1742020 - Neuron. 1991 Nov;7(5):695-702 – reference: 19847468 - J Neurol. 2010 Apr;257(4):540-5 – reference: 26756166 - Eur J Neurol. 2016 Mar;23 (3):630-40 – reference: 15635706 - Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134B(1):1-5 – reference: 19071096 - Brain Res. 2009 Feb 23;1256:123-8 – reference: 16442082 - Biol Psychiatry. 2006 May 1;59(9):812-5 – reference: 23769397 - Neurobiol Aging. 2013 Nov;34(11):2457-64 – reference: 12783434 - Ann Neurol. 2003 Jun;53(6):823 – reference: 7568031 - Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8856-60 – reference: 12666095 - Ann Neurol. 2003;53 Suppl 3:S16-23; discussion S23-5 – reference: 22001244 - J Clin Neurosci. 2011 Dec;18(12):1744-5 |
| SSID | ssj0000392393 |
| Score | 2.478537 |
| SecondaryResourceType | review_article |
| Snippet | Brain-derived neurotrophic factor (BDNF) has a unique role in the neuronal development, differentiation, and survival in the developing and adult nervous... |
| SourceID | pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 523 |
| SubjectTerms | Brain-derived neurotrophic factor Diagnosis Genetic aspects Genetic polymorphisms Neurodegenerative diseases Review |
| Title | BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29896439 https://www.proquest.com/docview/2054927194 https://pubmed.ncbi.nlm.nih.gov/PMC5988606 |
| Volume | 9 |
| WOSCitedRecordID | wos000434762200017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2152-5250 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000392393 issn: 2152-5250 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2152-5250 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000392393 issn: 2152-5250 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6FwoELAsojUMIioXIAi_i5NjeTUCFBogqClJu1a69bS60T5VG1HPgj_Flm1rt-pEICJC5RZE9sZ-fzzOzOzLeEvOQ-S0OfeVbGPWmBP44s4QnXcoVwYf6QRz4P1WYTbDoN5_PouNf7aXphLs5YWYaXl9Hyv6oajoGysXX2L9RdXxQOwHdQOnyC2uHzjxT_fjw9wrI2mNTDGOrCitgw6GPnyGYNlk5V2Bm21pHpj_yC7eaqi6AoXyvijkyeKGbqqsRIc3Wu2zFtfGIaHXeyPV9158fMuMfKuiirv70qmuIdTEJUuf9is6r9xKRYfedSVRtM5GlWtBco7LAppKqcx6fPO6ubZjtkqcwcbqxrYXK1bZOjFvTcln31q-Zk7ar9ijvlmhfwXLVPTTzG0j2GHIysLQfDvjxX2kf6eQzJGmdYlygeT0Z-FIYB0rnfdJgfocmc_GgW8IYQWbqRq3lb8ZZv2zdElml99U7Is-v4W5FPtyq3FebM7pI7en5C4wpX90hPlvfJfgyjuji_oodUVQyrVMw-SRFqtA21dzSmFdDoIqcANNoAjQJCqAEarYFGi5JeAxqtgfaAfDv6MBt9tPSmHVYKwffGSoXtcO7nQmTc9fIsyALO8jzKhnnAA-aIkHEhpPCZzDGJHWQ5uIiMpamTcR667kOyVy5K-ZjQaMjtNPcxse14meMLxx4GwpUsD5jgttcnb8y4JqlmtMeNVc4SnNmiRpJ4nKBGEtRInxzW4suKyuV3gs9RSUnViVzbhCTGrWQZpir75JWSQDTBHVOue1nguZFOrSN50JEE4512Tr8wQEjwFFY8lnKxXcPTIHcisyP4m48qYNRPbYDVJ6wDmVoAOeO7Z8riVHHHa0w_-edfPiW3m5f8gOxtVlv5jNxKLzbFejUgN9g8HKiFrYF6XX4B6ePrDg |
| linkProvider | ISSN International Centre |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=BDNF+Polymorphism%3A+A+Review+of+Its+Diagnostic+and+Clinical+Relevance+in+Neurodegenerative+Disorders&rft.jtitle=Aging+and+disease&rft.au=Shen%2C+Ting&rft.au=You%2C+Yuyi&rft.au=Joseph%2C+Chitra&rft.au=Mirzaei%2C+Mehdi&rft.date=2018-06-01&rft.pub=JKL+International+LLC&rft.eissn=2152-5250&rft.volume=9&rft.issue=3&rft.spage=523&rft.epage=536&rft_id=info:doi/10.14336%2FAD.2017.0717&rft_id=info%3Apmid%2F29896439&rft.externalDocID=PMC5988606 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2152-5250&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2152-5250&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2152-5250&client=summon |